Search for: "Teva Pharmaceuticals USA, Inc."
Results 121 - 140
of 489
Sort by Relevance
|
Sort by Date
23 Jul 2018, 2:38 pm
Mylan Pharmaceuticals Inc., Teva Pharmaceuticals USA, Inc., AKORN, Inc. [read post]
23 Jul 2018, 12:05 pm
Teva Pharmaceuticals USA, Inc., et al., No. 17-1229. [read post]
22 Jul 2018, 8:32 pm
IPR2016-01127, IPR2016-01128, IPR2016-01129, IPR2016-01130, IPR2016-01131, and IPR2016-01132 (and parallel IPRs filed by Petitioners Teva Pharmaceuticals USA, Inc. and Akorn, Inc., which had... [read post]
18 Jul 2018, 11:23 am
Teva Pharmaceuticals USA, Inc., a case with broad implications for the pharmaceutical industry. [read post]
13 Jul 2018, 5:48 pm
Teva Pharmaceuticals USA, Inc., is apertinent intervening case, but did not explain how it isan intervening change in law to the inherency doctrine,especially given that it is an on-sale bar case. 855 F.3d1356 (Fed. [read post]
5 Jul 2018, 7:20 am
Teva Pharmaceuticals, USA, Inc., 429 F.3d 1364 (Fed. [read post]
5 Jul 2018, 7:20 am
Teva Pharmaceuticals, USA, Inc., 429 F.3d 1364 (Fed. [read post]
26 Jun 2018, 8:51 pm
Teva Pharmaceuticals USA Inc., Docket No. 17-1229.... [read post]
26 Jun 2018, 8:17 am
Teva Pharmaceuticals USA, Inc. [read post]
26 Jun 2018, 8:17 am
Teva Pharmaceuticals USA, Inc. [read post]
25 Jun 2018, 7:51 am
Teva Pharmaceuticals USA: Whether, under federal patent law, an inventor’s sale of an invention to someone who is required to keep the invention confidential constitutes “prior art” for purposes of determining whether the invention is patentable. [read post]
25 Jun 2018, 7:03 am
Teva Pharmaceuticals USA Inc., Docket No. 17-1229. [read post]
21 Jun 2018, 4:00 pm
Teva Pharmaceuticals USA Inc. 17-1229 Issue: Whether, under the Leahy-Smith America Invents Act, an inventor’s sale of an invention to a third party that is obligated to keep the invention confidential qualifies as prior art for purposes of determining the patentability of the invention. [read post]
20 Jun 2018, 5:00 pm
Teva Pharmaceuticals USA Inc., 17-1229, the bar section will be completely full on the day it is argued. [read post]
18 Jun 2018, 9:15 am
Teva Pharmaceuticals USA, Inc., et al., No. 17-1229 (Supreme Court 2018), the petitioner has asked the Supreme Court to offer its statement on whether Congress altered the “on sale bar” to now apply only to non-confidential sales or offers. [read post]
7 Jun 2018, 4:59 pm
Ltd.; Teva Pharmaceuticals International GMGH; and Teva Pharmaceuticals USA, Inc. [read post]
18 Apr 2018, 1:02 pm
In Teva Pharmaceutical USA, Inc. v. [read post]
11 Apr 2018, 7:17 pm
Teva Pharmaceuticals USA Inc. 17-1229 Issue: Whether, under the Leahy-Smith America Invents Act, an inventor’s sale of an invention to a third party that is obligated to keep the invention confidential qualifies as prior art for purposes of determining the patentability of the invention. [read post]
30 Mar 2018, 7:13 am
Teva Pharmaceuticals USA, Inc., 1-14-cv-00878 (DED March 28, 2018, Order) (Stark, USDJ) [read post]
21 Mar 2018, 1:34 pm
Une de ces unicités a récemment refait surface dans la décision du Federal Circuit dans Helsinn Healthcare SA v Teva Pharmaceuticals USA Inc.: la mise en vente pouvant faire anticiper un dépôt de brevet américain. [read post]
